quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·15d
PRRelease
United Therapeutics Corporation logo

United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure

UTHR· United Therapeutics Corporation
Health Care
Original source

Companies

  • UTHR
    United Therapeutics Corporation
    Health Care

Recent analyst ratings

  • Apr 10UpdateRaymond James$700.00
  • Oct 20UpdateWells Fargo$414.00
  • Sep 26UpdateRBC Capital Mkts$569.00
  • Jun 2UpdateCantor Fitzgerald$405.00
  • Apr 25UpdateWells Fargo-
  • Apr 21UpdateBofA Securities$314.00

Related

  • INSIDER7h
    Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $146.03 and sold $5,477,366 worth of shares (9,500 units at $576.56) as part of a pre-agreed trading plan (SEC Form 4)
  • INSIDER1d
    SEC Form 4 filed by Rothblatt Martine A
  • PR1d
    United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026
  • INSIDER2d
    SEC Form 4 filed by Rothblatt Martine A
  • INSIDER2d
    SEC Form 4 filed by Edgemond James
  • INSIDER3d
    SEC Form 4 filed by Rothblatt Martine A
  • PR3d
    United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026
  • INSIDER6d
    SEC Form 4 filed by Patusky Christopher
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022